cabozantinib,atezolizumab
roche
['breast', 'contact3']
so unlike the analogy in breast cancer, ici on following progression on ici didn't improve pfs or os #contact3 study #asco23
A passionate oncologist who believes in fairness, dignity, and right for freedom, and respect
Chief Medical Officer, Erytech.